Clinical Research
Ractigen Therapeutics Doses First Patient in Phase I Trial of RAG-17 for SOD1-Linked ALS
Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing RNA-based innovative therapies, today announced the successful dosin...
December 25, 2024 | News
Daiichi Sankyo and AstraZeneca Withdraw EU Application for Datopotamab Deruxtecan in NSCLC
Daiichi Sankyo and AstraZeneca have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DX...
December 25, 2024 | News
10x Genomics Secures Permanent Injunction Against Bruker’s GeoMx Products Following Patent Infringement Verdict
10x Genomics, Inc. , a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for...
December 24, 2024 | News
Keymed Biosciences Secures NMPA Approval for Stapokibart to Treat Chronic Rhinosinusitis with Nasal Polyposis
Keymed Biosciences Inc. announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New D...
December 24, 2024 | News
SCG Cell Therapy Partners with A*STAR BTI and NATi to Accelerate RNA-Based Therapeutics Development and Commercialization
SCG Cell Therapy signed a Memorandum of Understanding (MoU) with A*STAR Bioprocessing Technology Institute (A*STAR BTI) and Nucleic Acid Therapeutics Ini...
December 23, 2024 | News
Lonza Opens State-of-the-Art R&D Facility in Slough, UK to Drive Biologics Innovation
Lonza, a global leader in biotechnology and pharmaceutical manufacturing, is proud to announce the opening of its new state-of-the-art research and develop...
December 19, 2024 | News
Sanofi and Teva Report Positive Phase 2b Results for Duvakitug in Ulcerative Colitis and Crohn’s Disease
Primary endpoints met in ulcerative colitis (UC) and Crohn’s disease (CD), the most common forms of inflammatory bowel disease (IBD) Primary endpo...
December 18, 2024 | News
Complete Genomics Partners with Eurofins Clinical Enterprise to Expand Access to Advanced Sequencing Services
Complete Genomics, a San Jose, California based genomics tools manufacturer, announced Framingham, Massachusetts based Eurofins C...
December 18, 2024 | News
Australia’s Cartherics Secures $300K G-Rex Grant to Advance Manufacturing of Allo CAR-iNK Cells for Ovarian Cancer Trials
- Cartherics has received a US$300K G-Rex grant to support its ‘in house’ manufacturing program- Funding will enable Cartherics to generate cru...
December 18, 2024 | News
Thermo Fisher Launches MagMAX™ Sequential DNA/RNA Kit to Simplify Genomic Analysis for Blood Cancer Research
Thermo Fisher Scientific has introduced the Applied Biosystems™ MagMAX™ Sequential DNA/RNA kit to enable clinical and translational researchers...
December 18, 2024 | News
Innovent Biologics and Lilly Collaborate to Bring Novel BTK Inhibitor Jaypirca® to Mainland China
Innovent Biologics, Inc. , a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment ...
December 16, 2024 | News
HiRO Partners with South Korea’s CHA Bundang Medical Center to Advance Global Clinical Trials
Harvest Integrated Research Organization (HiRO), a boutique global clinical research organization (CRO) providing cross-border clinical trial sol...
December 16, 2024 | News
ADELA Phase III Trial Combines Elacestrant and Everolimus to Tackle Advanced ER+/HER2- Breast Cancer with ESR1 Mutations
ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breas...
December 13, 2024 | News
CellProthera and SKGH Forge Alliance to Advance CD34+ Cell Therapy for Ischemic Diseases in Japan
CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced a new memorandum of understanding with Shonan Kamakur...
December 13, 2024 | News
Most Read
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
